 |
市場調査レポート
商品コード
1373760
脳インプラントの世界市場 - 市場規模、シェア、成長分析：タイプ別、用途別、エンドユーザー別 - 業界予測（2023年～2030年）Global Brain Implant Market Size, Share, Growth Analysis, By Type(Deep brain stimulation (DBS) and vagus nerve stimulation (VNS).), By Application(Parkinson's disease, epilepsy), By End user(Hospitals, neurology clinics) - Industry Forecast 2023-2030 |
||||||
| 脳インプラントの世界市場 - 市場規模、シェア、成長分析：タイプ別、用途別、エンドユーザー別 - 業界予測（2023年～2030年） |
|
出版日: 2023年10月09日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の脳インプラントの市場規模は2021年に12億5,000万米ドル米ドル、2022年に14億米ドルとなりました。同市場は、予測期間中（2023年～2030年）に12.2%のCAGRで拡大し、2030年には35億2,000万米ドルに成長する見通しです。
世界の脳インプラント市場は、技術の進歩と神経疾患の有病率の上昇に牽引され、着実な成長を遂げています。脳インプラントは、神経インプラントまたは神経人工器官としても知られ、様々な神経疾患の診断、モニタリング、治療を行うために脳とインターフェースする移植医療機器です。てんかん管理やパーキンソン病治療から認知機能強化やブレイン・コンピュータ・インターフェイスまで幅広い用途があり、脳インプラントは有望な治療選択肢を提供します。Medtronic、Abbott Laboratories、Boston Scientificをはじめとする市場の主な参入企業は、脳インプラント技術を進歩させるために研究開発に投資しています。小型化、電極設計の改良、人工知能アルゴリズムとの統合といった技術の進歩は、脳インプラントの有効性と安全性を高めています。しかし、インフォームド・コンセントやデータ保護など、脳インプラントを取り巻く倫理的・プライバシー的な配慮は、この分野が進化し続ける中で対処される必要があります。
パーキンソン病、てんかん、慢性疼痛などの神経疾患の罹患率と有病率の上昇が、脳インプラント技術の需要を牽引しています。これらのインプラントは、症状を管理し、患者の生活の質を改善するための効果的な治療オプションを提供します。
世界の脳インプラント市場における主要な市場動向の1つは、インプラントデバイスの小型化とワイヤレス接続への注目が高まっていることです。技術の進歩により、より小型でコンパクトな脳インプラントが開発され、外科手術の侵襲性が軽減され、患者の快適性が向上しています。小型化されたインプラントは、経頭蓋磁気刺激（TMS）や非侵襲的電気刺激法など、低侵襲的、あるいは非侵襲的アプローチの可能性を提供します。このような進歩は、長期的な埋込みから恩恵を受ける可能性のある患者にとって特に重要であり、小型化されたデバイスは合併症のリスクを軽減し、埋込みや取り外しが容易になるからです。
当レポートは、世界の脳インプラント市場について調査し、市場の概要とともに、タイプ別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。
目次
エグゼクティブサマリー
親市場分析
市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 動向分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品分析
- マクロ経済指標
- トップ投資分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制状況
- ポーター分析
世界の脳インプラント市場、タイプ別
- 市場概要
- 脳深部刺激（DBS）と迷走神経刺激（VNS）
世界の脳インプラント市場、用途別
- 市場概要
- パーキンソン病
- てんかん
- その他
世界の脳インプラント市場、エンドユーザー別
- 市場概要
- 病院
- 神経内科クリニック
- その他
世界の脳インプラント市場、地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
競合情勢
- 主要企業プロファイル
- Medtronic
- Abbott Laboratories
- Boston Scientific Corporation
- NeuroPace
- Cochlear Limited
- LivaNova PLC
- Stryker Corporation
- Nevro Corporation
- NDI Medical
- Nihon Kohden Corporation
- Second Sight Medical Products, Inc.
- Aleva Neurotherapeutics SA
- Renishaw plc
- Cyber??onics, Inc.
- Neuronetics, Inc.
- Natus Medical Incorporated
- BrainLab AG
- St. Jude Medical, Inc.
- NeuroSigma, Inc.
- Alpha Omega Engineering
Global Brain Implant Market size was valued at USD 1.25 billion in 2021 and is poised to grow from USD 1.4 billion in 2022 to USD 3.52 billion by 2030, at a CAGR of 12.2% during the forecast period (2023-2030).
The global brain implant market has been experiencing steady growth, driven by advancements in technology and a rising prevalence of neurological disorders. Brain implants, also known as neural implants or neuroprosthetics, are implanted medical devices that interface with the brain to diagnose, monitor, and treat various neurological conditions. With applications ranging from epilepsy management and Parkinson's disease treatment to cognitive enhancement and brain-computer interfaces, brain implants offer promising therapeutic options. Key players in the market, including Medtronic, Abbott Laboratories, and Boston Scientific, invest in research and development to advance brain implant technologies. Technological advancements, such as miniaturization, improved electrode designs, and integration with artificial intelligence algorithms, are enhancing the efficacy and safety of brain implants. However, ethical and privacy considerations surrounding brain implants, such as informed consent and data protection, need to be addressed as the field continues to evolve.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Brain Implant Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Brain Implant Market Segmental Analysis
The global brain implants market is segmented based on type, application, end user, and region. In terms of type, the market is divided into deep brain stimulation (DBS) and vagus nerve stimulation (VNS). DBS involves the implantation of electrodes to deliver electrical impulses to specific brain areas, while VNS utilizes electrical stimulation of the vagus nerve for neurological treatment. The market is categorized by application into Parkinson's disease, epilepsy, and other conditions. The end users of brain implant devices include hospitals, neurology clinics, and other healthcare settings. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Brain Implant Market
Increasing Prevalence of Neurological Disorders
- The rising incidence and prevalence of neurological disorders such as Parkinson's disease, epilepsy, and chronic pain are driving the demand for brain implant technologies. These implants offer effective treatment options for managing symptoms and improving patients' quality of life.
Restraints in the Global Brain Implant Market
Ethical and Privacy Concerns
- The use of brain implants raises ethical concerns related to informed consent, privacy, and potential misuse of brain data. The invasive nature of brain implant procedures also poses risks and requires careful consideration of the potential benefits and long-term implications for patients.
Market Trends of Global Brain Implant Key
- One key market trend in the global brain implant market is the increasing focus on miniaturization and wireless connectivity of implantable devices. Advancements in technology have led to the development of smaller, more compact brain implants, reducing the invasiveness of surgical procedures and enhancing patient comfort. Miniaturized implants offer the potential for minimally invasive or even non-invasive approaches, such as transcranial magnetic stimulation (TMS) or non-invasive electrical stimulation techniques. These advancements are particularly important for patients who may benefit from long-term implantation, as smaller devices can reduce the risk of complications and allow for easier implantation and removal.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Brain Implant Market by Type
- Market Overview
- Deep brain stimulation (DBS) and vagus nerve stimulation (VNS).
- Global Brain Implant Market by Application
- Market Overview
- Parkinson's disease
- epilepsy
- and other conditions
- Global Brain Implant Market by End user
- Market Overview
- Hospitals
- neurology clinics
- and other healthcare settings
- Global Brain Implant Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Medtronic (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroPace (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cochlear Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nevro Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NDI Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nihon Kohden Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Second Sight Medical Products, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aleva Neurotherapeutics SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Renishaw plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cyberonics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Neuronetics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Natus Medical Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BrainLab AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- St. Jude Medical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroSigma, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alpha Omega Engineering (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
